List of Equipment Companies in China - 23

Beijing Challen Biotechnology Co., Ltd., located in Zhongguancun Science and Technology Park Biological Pharmaceutical Industry Base, Daxing District, Beijing, is a technology company specializing in the R&D, production and sales of biomedical technology products. Challen Biotechnology is committed to providing users with excellent one-stop services of flow cytometry (FCM), instruments and reagents. At present, its products mainly cover LongCyte™ and FongCyte™ FCM series, as well as auxiliary diagnostic reagent and automatic sample preparation instruments. There are nearly 300 users in China. Challen Biotechnology also provides solutions for clinical diagnosis, biotherapy, basic biomedical research, drug R&D, environmental materials, food toxicity monitoring, etc.

BioTeke Corporation is a provider of molecular diagnostics instrument & related reagents. built at 2005, headquarter locates in Beijing, and factory in Wuxi city. We offer kinds of lab instruments as: Automated nucleic acid extraction system; UV-Vis spectrophotometer; 96 Gradient PCR; Centrifuge; Tip Rack Refill system; Automated liquid handling system; Gel imaging system And we also provide more than 100 kinds of DNA/RNA/Protein extraction reagents. Bioteke holds the philosophy to offer quick molecular diagnostic products with low price,high quality and superior services to the world.

Bliss Biopharmaceutical (Hangzhou) Co., Ltd. is a clinical-stage biotech company dedicated to the discovery, development, and commercialization of anti-tumor biotherapeutics. With the core value of 'Together, We Improve Human Health,' the company focuses on multi-level collaborations and developments to advance its mission.

CSPC Pharmaceutical Group Limited is a leading pharmaceutical company based in Shijiazhuang, Hebei, China. The company focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. With a strong emphasis on innovation, CSPC has a robust research and development team of over 2,000 members, including many with advanced degrees and international experience. Their R&D efforts span multiple locations, including Shijiazhuang, Shanghai, Beijing, and the United States. CSPC offers a diverse array of pharmaceutical products, including finished drugs like capsules, tablets, and injections, as well as bulk drugs such as active pharmaceutical ingredients. Their product range addresses various therapeutic areas, including oncology, cardiovascular health, respiratory conditions, anti-infectives, and diabetes management. The company also has an extensive pipeline of over 300 projects focused on innovative drug development, highlighting its commitment to advancing healthcare solutions. CSPC's products are available in multiple regions, including the Americas, Europe, and Asia, serving a broad customer base in the healthcare sector.

Great Bay Bio (GBB), based in Hong Kong, is an innovative biotech company with a vision of Disruptive Revolution of Biologics Development. Committed to utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development, and in industries involving bioprocessing, e.g., synthetic biology, IVD and CGT. Led by a team of experienced professionals in biopharmaceuticals and AI, GBB's members boast over 20 successful IND filings approved by both China and the United States. GBB has launched multiple proprietary AI biotech platforms; AlfaCell, an AI-enabled site-specific integration cell line development platform that resolves multiple developmental bottlenecks, including unpredictable cell line stability and labor-intensive screening during CLD. Additionally, the AlfaMedX platform is an AI-enabled cell culture media development platform, responsible for creating over 50 unique cell culture media that outperform commercially available CHO cell culture media. GBB has secured 40+ patent applications, related to AI-enabled biological platform. Recognizing the potential of these platforms, GBB has formed partnerships with over 20 leading domestic and international companies.

Founded in 1992 and listed in 2015, Wondfo is a fast-growing biotechnology company in China. Wondfo mainly focuses on rapid diagnostics in China but is looking for further development in other areas of the healthcare industry. Besides the headquarter in Guangzhou, Wondfo also owns 2 overseas labs, 1 branch in Chicago, and 11 overseas offices. After many years’ efforts in delivering high-quality products and services, Wondfo has won a good reputation around the world. In production, Wondfo strictly complies with national and international regulations and standards. We have got CE certificates, FDA certificates, FSC certificates, ISO 9001:2008, and ISO 13485:2012 quality system certification. Wondfo attaches great importance to research and development and sees innovation as the soul of the enterprise’s development. So far, Wondfo has 530+ highly-qualified researchers and over 30% of the staff have obtained master's and doctorate degrees from prestigious universities worldwide. Wondfo also has built R&D laboratories in Guangzhou and San Diego. With our advanced production lines and highly experienced staff, Wondfo’s daily production capacity of test kits reaches 1.5 million. Wondfo also provides a number of customized services to professional distributors and partnering affiliates. Wondfo provides high-quality products at a very competitive price, together with professional technical support and counseling service. Currently, Wondfo has customers in more than 120 countries and areas. It is our commitment to safeguarding the health and improving lives with better products, services, and solutions. With more than 3000 dedicated employees, we'll continue to innovate and shape the future of POCT and healthcare.

Establish in 2008 in China Hangzhou city, Biotest is mainly engaged in the R&D, production and sales of in vitro diagnostic reagents, divided into 5 catagories: drug abuse testing, infectious desease testing, fertility health, tumor marker testing and cardiology market testing. E-mail: info-B@biotests.com.cn Nous sommes spécialisés dans la R&D, la production et la commercialisation des réactifs de laboratoire, surtout des tests de dépistage rapide depuis 14 ans et nous travaillons avec plus de 500 professionnels dans le domaine médical. Nous attachons une grande impportance à la qualité et la prise en charge du client. Contactez le +86 571 8905 8143 pour plus d'information.

Founded in 2015 with the pursuit for human and global health,Testsealabs Inc.creates innovative tech-nologies for the development of raw materials for diagnostic use.We offer diagnostic total solution such as rapid diaqnostic tests(RDTs),fluorescent immuno-diaqnostic tests, ELISA,molecular diagnostic tests(MDx)and clinical chemistry. We specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in China.We also have patented technoloqies includingfluorescentimmuno-diagnostics which will be one of the major IVD technologies of the future. Our facility is GMP,ISO9001and ISO13458 certified and we have CE FDA approval. Now we are looking forward to cooperating with more overseas companies for mutual development. Since its establishment,Testsealabs Inc has always insisted on R&D and innovation. At present, it has accumulated 1 software copyright and 50 authorized patents, including 4 invention patents, 46 new patents for use, and several special projects under application. Testsealabs Inc currently has more than 300 employees, an annual output of 300 million people, and a business area of 56,000 square meters. We pursuing the concept of "integrity, quality and responsibility", adhering to the tenet of quality first and serving the society, we constantly strive to develop new high-quality diagnostic raw materials, always adhere to the vision of serving the society and a healthy world, and are committed to promoting high-quality diagnostic products. Accurate diagnosis of all human diseases contributes to the cause of human health. Always find us here for solutions!

Landwind Medical has been a professional medical equipment manufacturing company since 1994. With over 25 years of experience in the medical industry, today, Landwind has six R&D centers and four production lines around China, besides Shenzhen's headquarters. Also, Landwind has perceptive R&D teams of 300+ professionals with medical practice and product development backgrounds. Landwind Group has four subsidiaries manufacturing different categories of medical products: Landwind Bio: for in-vitro diagnostic equipment and reagent solutions; Joyheal: for hemodialysis solutions; Landsky: is a specialist in ventilator & anesthesia solutions; Landwind Health: for home care/medical solutions. Professionally, Landwind is accumulating, gaining many professional awards and certificates every year, among them the CE, ISO9001, and CMD certificates, besides hundreds of local awards, Medical Device Manufacturing certificates, and patents. Landwind's products and professional staff are always on the front line with medical companies in most medical exhalation and fairs early, aiming to expand its cooperation network and open new markets. Landwind Medical's distributing network exceeds 800 and has more than 120,000 active clients covering more than 150 countries.

Membrane Solutions is a rising, creative and world-wide supplier who specializes in a variety of products and solutions in the process of filtration, separation, purification, water & wastewater treatment. Nowadays, our business covers more than 109 countries and regions all over the world, we offer trustworthy products, considerate service as well as consistent innovation in technique. THREE fast growing divisions: Lab Filtration—HPLC and filtration (Syringe Filter, Sample Vials, Membrane Filter etc.) Residential Water Treatment—RO Membrane & Filter, UF Membrane & Filter, Water Purifier & Water Pitcher, Portable Water Treatmetn Devices etc. Industrial Filtration & Water Treatment—Pleated Membrane Cartridge Filter, UF Membrane, MBR Membrane, Integrated Membrane Water Treatment System etc. MS Advantages: Continuously devotion to research & development Mastery for various production craft and technology High quality and value products Globalization of production and customer support Sustainable and stable product supply Close relations with customers Membrane Solutions contribute to the human society by creating innovative technology and value for clean water and environment.

Founded in 2016, MGI has more than 900 employees, nearly half of whom are R&D personnel. MGI operates in 26 countries and regions and has established multiple research and production bases around the world. MGI develops DNA sequencingand related instrumentation.

Founded in 2014, China Analytical is an automation and solution provider in life sciences and biopharmaceuticals, forensics, clinical diagnostics, public health epidemiology and food quality and safety, covering instruments, reagents, consumables, software and services. Headquartered in Suzhou, with a branch in Wuhan for Central China and Nanjing for East China, we help scientists, researchers and healthcare professionals solve full automation challenges and make analysis more efficient and automated. We build strategic partnerships with our customers, leveraging our market knowledge and technical expertise to help them get more accurate results sooner.

Qitan Technology is a developer of genome sequencing technology, specializing in nanopore sequencing. The company has released datasets and publications related to its technology and has made significant technological achievements in the field of genetic code information.

Reetoo is a leading company for AI-driven IVD equipments in the world with revolutionary and innovative IVD equipments for blood, leucorrhea, sperm, urine, and tissues; All of our products are fully automatic in the whole process based on our AI-driven DeepCell engine,which can greatly improve doctors' efficiency and save a lot of time for doctors and patients.We are looking for distributors globally now,please contact us if you are interesting.

SinoTherapeutics is a specialty pharma focus on the R&D, registration, manufacture and commercialization of complex generic products as well as innovative formulation products (505B2). The company aims to achieve commercialize its product globally, and to provide cost-effective high-quality products to international markets

Founded by the multidisciplinary team of scientists and engineers in 2016, Beijing Transcend Vivoscope Bio-Technology Co., Ltd. has grown into one of the most innovative companies in China. With its cutting-edge miniature multi-photon microscopy technology, Transcend Vivoscope has specialized in providing the most advanced imaging products and solutions to empower neuroscience researches worldwide.  In 2017, the company acquired clear images of the brain cells and subcellular structures of free-behaving mice for the first time in the world, and has since then developed and commercialized a series of miniature two-photon and three-photon microscopy imaging systems for neuroscience. This technology with other free-moving animal imaging technology was awarded “Method of the Year 2018: Imaging in freely behaving animals” by Nature Methods.

VivaChek is a leading in-vitro diagnostics company dedicated to enhancing the quality of life by delivering precise and swift disease diagnoses. Our commitment lies in the advancement of healthcare through ongoing research and development in blood glucose monitoring systems, Hemoglobin & Lipid Testing System, FIA Testing System, lateral flow rapid test and Molecular Diagnostics. Our expertise encompasses the development, manufacturing, and distribution of top-tier biosensors and Point-of-Care Testing (POCT) products. Our biosensor offerings span a range of critical parameters, encompassing blood glucose monitoring systems, lactate analyzers, blood ketone meters, and uric acid analyzers. In addition to biosensors, our comprehensive POCT product portfolio includes state-of-the-art PCR, immunoassay, and biochemistry solutions. With a focus on precision, efficiency, and accuracy, our POCT products cater to diverse medical needs, contributing to the rapid and reliable diagnosis of various health conditions.

West China Hospital, Sichuan University is a healthcare institution that provides tertiary medical services and is the largest single hospital in the world.

Dongguan Xinyi Biotechnology Co., Ltd. which is established in 2022 in dongguan, is a cosmetics company specializing in production, sales and marketing With first-class production technology and equipment, the company is committed to the research and development . production and sales of high-tech cosmetics, as well as the directional application of traditional Chinese medicine plant raw materials, biological extraction raw materals and functional raw materials. We have cooperated with Australia, Canada and other foreign cooperative manufacturers and professional research institutions to carry out project cooperation, to introduce of advanced management system and cutting-edge science and technology, to develop of domestic first-class, cost-effective personal care products.

The company was founded in December 2005, built a variety of plant and GMP workshop, office space, auxiliary housing, with various types of imports and domestic advanced equipment. The company is a professional R&D, production, sales of rapid in vitro diagnostic reagents of the national high-tech enterprises, Zhejiang Province post-doctoral research station and Huzhou City academician expert workstation set up units. At present, the company's products are widely used in Infectious Disease Rapid Test, Drugs of Abuse Test, Pregnancy & Fertility Tumor Marker Cardiac Marker and other fields, with repeatability and specificity, high sensitivity, easy to operate and other technical characteristics. During the outbreak, the company's new coronavirus testing reagents are widely sold to all corners of the globe. It has made outstanding contributions to the fight against the new coronavirus for all mankind. Since its inception, the company to scientific and technological innovation as the driving force for development, committed to the cause of human health, in order to promote high-tech diagnosis and treatment technology, improve the level and quality of human medical services and efforts. At present, the majority of the company's products have been CE certificated. The company now hopes to expand into the European market. Find local partners in Europe. Better service to the European market.

Zhuhai Livzon DiagnosticsInc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of thelisted company, Livzon Pharmaceutical Group (A-shareand H-share listed company),whospecializing in in-vitro diagnosticsin research, developing, manufacturingand marketing of diagnosis productsand automation equipment.Diagnostic Kit for IgM/IgG Antibody to Coronavirus (SARS-CoV-2) (Colloidal Gold)

More than a decade ago, with the goal of Setting New Standards in Price and Performance, SonoScape specialized itself in ultrasound diagnostic systems and transducers. In 2004 SonoScape released the world's first 15 inch LCD portable color Doppler Ultrasound System. Shortly afterwards SonoScape's product received FDA approval and CE certification and started to be serviced all over the world. Motivated by our goal, we have established a global R&D team with research centers in China and abroad to make the innovative medical technologies accessible and affordable. To reach this goal, SonoScape has continuously introduced new medical products and technologies into the market every year. Consequently SonoScape has expanded into the fields of Endoscopy and Minimally Invasive Surgery to continue providing better healthcare solutions to the world for the purpose of meeting the diagnostic needs of our worldwide customer base. With the Value Proposition of "Unlocking Life's Potential",​ SonoScape has developed and manufactured high quality medical equipment which has benefited millions of people. SonoScape products have become indispensable tools for doctors and clinicians world wide when making critical decisions and reducing their workload. Inspired by the medical needs of the world, we shall continue to dedicate ourselves to delivering meaningful and accessible medical solutions to change lives for the better.